Antibacterial and Anti-Inflammatory Potential of Polyherbal Formulation Used in Chronic Wound Healing

Table 7

MIC values of JT extracts against reference bacterial strains.

MIC, mg/mL^a
Reference bacterial strains	Gram (±)	JTYG-EE	JTYG-Hex	JTAFI-EE	JTAFI-Hex	Gentamicin control	Streptomycin control
S. aureus ATCC 25923	+	7.81	7.81	15.60	31.25	≤0.0156	0.0019
MRSA ATCC 33592^b	+	15.60	31.25	15.60	31.25	ND^c	ND
S. epidermidis RP62 A	+	1.95	1.95	15.60	31.25	0.012	≤0.0780
E. faecalis ATCC 29212	+	31.25	62.50	62.50	NI^d	0.0039	0.0048
E. coli ATCC 25 922	−	62.50	NI	31.25	NI	0.0015	0.0039
P. aeruginosa ATCC 27853	−	15.60	NI	62.50	NI	0.2500	0.0078
P. aeruginosa MDR ATCC BAA-2108^e	−	NI	62.5	62.50	NI	ND	ND
P. mirabilis ATCC 29245	−	NI	NI	NI	NI	≤0.00003	0.0780
K. pneumoniae ATCC 33495	−	62.50	NI	62.50	NI	≤0.0007	0.0004

^aMICs were determined by broth microdilution method and all experiments were done in triplicate; ^bMICs were determined as 0.125 µg/mL to ciprofloxacin and 1.5 µg/mL to vancomycin; ^cND: not determined; ^dNI: no inhibition; ^eMICs were determined as > 32 µg/mL to imipenem and ciprofloxacin.